Improving HCV Outcomes in Rural and Underserved Communities: Listening and Engaging Patients in Care " Part 2

Target Audience
This activity is designed specifically for primary care clinicians, nurses, and other members of the healthcare team who serve patients in rural and underserved communities.

Program Overview
In recent years, the advance of direct-acting antivirals has resulted in dramatically increased cure rates for hepatitis C virus (HCV) infection and improved patient outcomes. However, HCV still remains a public health concern in the United States, particularly in rural and underserved populations that continue to be disproportionately affected by the condition. In this activity, expert faculty will review available treatment regimens for HCV, guideline-based recommendations for treatment-naïve and treatment-experienced patients, and strategies to overcome barriers to care in rural and underserved areas. Best practices for managing special populations with HCV including people who inject drugs and pregnant women will also be discussed.

This activity was recorded from a live webcast on January 14, 2023. Please note that data, information, and guidance presented in the video are subject to change.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Compare available treatment regimens for patients with HCV based on efficacy, safety, dosing profiles, and other differentiating characteristics
Describe guideline-based treatment recommendations for treatment-naïve vs treatment-experienced patients with chronic HCV
Employ strategies for engaging patients with HCV in shared decision-making to optimize outcomes and promote patient-centered care